Значения термина xyrem на английском

Xyrem is an approved treatment for excessive daytime sleepiness and cataplexy in patients with narcolepsy.

Xyrem is the only approved treatment for both excessive daytime sleepiness and cataplexy in patients with narcolepsy, a chronic neurological disorder.

Dublin-based Jazz Pharmaceuticals said revenues rose 15 per cent in the second quarter of the year as sales of its Xyrem product increased.

Jazz Pharmaceuticals, the Dublin-based maker of the narcolepsy treatment Xyrem, is buying Italian rare disease drug developer Gentium in a $1 billion deal.

The committee also backed extending the use of Belgian group UCB's UCBBt.BR Xyrem to treat narcolepsy with cataplexy, or a sudden loss of muscle tone.

Xyrem generated sales of $816.4 million in the nine months ended Sept. 30, representing about 75 percent of Jazz Pharma's net product sales.